- Researchers found a distinct blood signature in children with Long COVID with 93% accuracy. Published in Pediatric Research, the study assessed blood plasma proteins from 34 children with the disease and compared them with healthy controls, children with acute COVID-19, and children with MIS-C. “Long COVID was characterized by higher expression of the proinflammatory and pro-angiogenetic set of chemokines,” the authors wrote. Read more about the search for Long COVID biomarkers in this recent story.
- A new study in Scientific Reports found that 61% of people with postural orthostatic tachycardia syndrome (POTS) had abnormal blood flow to the head. The study, which included 56 participants from a POTS patient registry in Australia, used results from an imaging tool called brain SPECT to investigate the potential cause of cognitive dysfunction. The authors write that decreased blood flow to the head is “prevalent in those with POTS and cognitive dysfunction even whilst supine, contributing to reduced quality of life.”
- Mount Sinai’s Cohen Center for Recovery from Complex Chronic Illnesses (CoRE) is recruiting for an upcoming clinical trial for Long COVID using microtesla magnetic therapy (MMT). MMT is a type of therapy that exposes the body to weak magnetic fields, and has been used to treat some chronic degenerative diseases. The study will last for eight weeks and requires three in-person visits. Contact: CoreResearch@mountsinai.org.
One response
[…] The Sick Times: Research updates, February 4 […]